TPWA
RMD icon

Twin Peaks Wealth Advisors’s ResMed RMD Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-365
Closed -$81.9K – 1762
2026
Q1 		$81.9K Buy
+365
New +$91K 0.02% 322
2025
Q3 		– Sell
-317
Closed -$89.7K – 1673
2025
Q2 		$89.7K Buy
+317
New +$75.6K 0.03% 245

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Twin Peaks Wealth Advisors's RMD Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 365 shares — an estimated $81.9K sold.

Twin Peaks Wealth Advisors first reported a position in RMD in Q2 2025 and held it in 2 quarters. The position peaked at $89.7K in Q2 2025. 890 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 365 ResMed shares in Q2 2026, an estimated $81.9K.
  • Twin Peaks Wealth Advisors first reported a position in ResMed in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's ResMed position peaked at $89.7K in Q2 2025.
  • 890 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.